Caldesmon (BSB-19 (CALD-31)) Mouse
Caldesmon (BSB-19 (CALD-31)) Mouse
| Application | IHC |
| Clone | BSB-19 (CALD-31) |
| Conjugué | Unconjugated |
| Conseil | |
| Couleur | |
| Hôte | Mouse |
| Immunogène | Synthetic peptide corresponding to the N-terminus of the human caldesmon protein |
| Isotype | IgG1 kappa |
| Localisation | Cytoplasmic |
| Pathologie | Breast Cancer, Sarcoma, Soft Tissue |
| Predicted reactivity | |
| Purification | |
| Réactivité | Human |
| Spécificité | |
| Taille | |
| Tissus controles | Appendix, Uterus, Breast Ducts, Leiomyoma, Colon, Prostate, Skin, Kidney, Myometrium |
Prêt à l'emploi
| Conditionnement | Reference | Supplier | Certification | Dilution | TDS | Quantity |
|---|---|---|---|---|---|---|
| 7 ml | BSB6100 |
|
IVD/CE | RTU |
|
|
| 15 ml | BSB6101 |
|
IVD/CE | RTU |
|
|
| 3 ml | BSB6099 |
|
IVD/CE | RTU |
|
Concentré
| Conditionnement | Reference | Supplier | Certification | Dilution | TDS | Quantity |
|---|---|---|---|---|---|---|
| 0,1 ml | BSB6102 |
|
IVD/CE | 1/100 - 1/500 |
|
|
| 0,5 ml | BSB6103 |
|
IVD/CE | 1/100 - 1/500 |
|
|
| 1 ml | BSB6104 |
|
IVD/CE | 1/100 - 1/500 |
|
Control Slides
| Conditionnement | Reference | Supplier | Certification | Dilution | TDS | Quantity |
|---|---|---|---|---|---|---|
| 5 slides | BSB6105 |
|
IVD/CE |
|
||
| 5 slides | BSB9052-CS |
|
IVD/CE |
|